These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8164730)

  • 1. Human genetics. Bad blood by mutation.
    Majerus PW
    Nature; 1994 May; 369(6475):14-5. PubMed ID: 8164730
    [No Abstract]   [Full Text] [Related]  

  • 2. Activated protein C resistance--a major risk factor for thrombosis.
    Rosén SB; Sturk A
    Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to activated protein C--diagnostic strategy in a laboratory of haemostasis.
    Aillaud MF; Succo E; Alessi MC; Gandois JM; Gallian P; Morange P; Juhan-Vague I
    Thromb Haemost; 1995 Oct; 74(4):1197-8. PubMed ID: 8560435
    [No Abstract]   [Full Text] [Related]  

  • 4. [Breakthrough in thrombosis research--can the use of contraceptive pills be safer than it used to be?].
    Lähteenmäki P
    Duodecim; 1995; 111(22):2097-8. PubMed ID: 9841168
    [No Abstract]   [Full Text] [Related]  

  • 5. Inherited thrombophilias.
    Laffan MA; Tuddenham EG
    QJM; 1997 Jun; 90(6):375-8. PubMed ID: 9205674
    [No Abstract]   [Full Text] [Related]  

  • 6. Mutation in blood coagulation factor V associated with resistance to activated protein C.
    Bertina RM; Koeleman BP; Koster T; Rosendaal FR; Dirven RJ; de Ronde H; van der Velden PA; Reitsma PH
    Nature; 1994 May; 369(6475):64-7. PubMed ID: 8164741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to activated protein C caused by the factor VR506Q mutation is a common risk factor for venous thrombosis.
    Dahlbäck B
    Thromb Haemost; 1997 Jul; 78(1):483-8. PubMed ID: 9198201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to activated protein C: a major cause of inherited thrombophilia.
    Jensen R; Ens GE
    Clin Lab Sci; 1997; 10(4):219-22. PubMed ID: 10169621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Factor V Leiden and thrombophilia].
    Mahassen P; Dicato M
    Bull Soc Sci Med Grand Duche Luxemb; 1997; 134(2):17-22. PubMed ID: 9534269
    [No Abstract]   [Full Text] [Related]  

  • 10. [Venous thrombosis in a pregnant woman heterozygous for factor V Q506 mutation].
    Chabane MH; Alhenc-Gelas M; Pathier D; Siguret V; Andreux JP; Gaussem P
    Ann Biol Clin (Paris); 1998; 56(1):112-3. PubMed ID: 9754234
    [No Abstract]   [Full Text] [Related]  

  • 11. [Resistance to activated protein C disclosed by postphlebitic disease. Two cases].
    Foueré S; Lestang P; Cosnes A; Gouault-Heilmann M; Revuz J
    Ann Dermatol Venereol; 1996; 123(1):24-5. PubMed ID: 8734112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent deep vein thrombosis and two coagulation factor gene mutations: quo vadis?
    Lensing AW; Prins MH
    Thromb Haemost; 1999 Dec; 82(6):1564-6. PubMed ID: 10613635
    [No Abstract]   [Full Text] [Related]  

  • 13. Are we ready for factor V Leiden screening?
    Dahlbäck B
    Lancet; 1996 May; 347(9012):1346-7. PubMed ID: 8637335
    [No Abstract]   [Full Text] [Related]  

  • 14. [APC resistance and blood coagulation factor V mutation in Finnish thrombotic patients].
    Hakala L; Vahtera E; Krusius T; Rasi V
    Duodecim; 1995; 111(22):2143-51. PubMed ID: 9841174
    [No Abstract]   [Full Text] [Related]  

  • 15. Alternative PCR method for diagnosis of mutation causing activated protein C resistant Gln506-factor V.
    Greengard JS; Xu X; Gandrille S; Griffin JH
    Thromb Res; 1995 Dec; 80(5):441-3. PubMed ID: 8588206
    [No Abstract]   [Full Text] [Related]  

  • 16. Resistance to activated protein C and a novel factor V gene mutation.
    Voelkerding KV
    Clin Lab Med; 1996 Mar; 16(1):169-86. PubMed ID: 8867589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor V Leiden--an unselfish gene?
    Hajjar KA
    N Engl J Med; 1994 Dec; 331(23):1585-7. PubMed ID: 7969330
    [No Abstract]   [Full Text] [Related]  

  • 18. New molecular insights into the genetics of thrombophilia. Resistance to activated protein C caused by Arg506 to Gln mutation in factor V as a pathogenic risk factor for venous thrombosis.
    Dahlbäck B
    Thromb Haemost; 1995 Jul; 74(1):139-48. PubMed ID: 8578447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factor profiles in patients with different clinical manifestations of venous thromboembolism: a focus on the factor V Leiden mutation.
    Manten B; Westendorp RG; Koster T; Reitsma PH; Rosendaal FR
    Thromb Haemost; 1996 Oct; 76(4):510-3. PubMed ID: 8902987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human longevity and R506Q factor V gene mutation.
    Faure-Delanef L; Quéré I; Zouali H; Cohen D
    Thromb Haemost; 1997 Sep; 78(3):1160. PubMed ID: 9308772
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.